Ms. Gilbert has served on Achaogen’s board of directors since January 2017. Since 2008, Ms. Gilbert has served as Senior Vice President, Chief Legal Officer of Ironwood Pharmaceuticals, providing leadership and oversight and establishing the company’s compliance function as Ironwood grew from a privately-held, research-based organization to a publicly-traded, fully-integrated commercial biotechnology company. Ms. Gilbert brings significant s trategic leadership and two decades of experience navigating biopharmaceutical companies through transformational change, as well as expertise in corporate transactions, corporate governance, employment law and legal and operational issues relevant to launching new medicines into specialty and primary care markets. Prior to joining Ironwood, Ms. Gilbert was Vice President, Deputy General Counsel at Cubist Pharmaceuticals from 2002 to 2008, where she supported the launch of Cubist’s first acute care antibiotic. From 1991 to 2001, Ms. Gilbert served as Corporate Counsel at Genzyme Corporation. Ms. Gilbert began her career at Skadden, Arps, Slate, Meagher & Flom LLP, where she specialized in mergers and acquisitions and securities law.
Ms. Gilbert holds a J.D. from Northwestern University School of Law and a B.A. from Tufts University.